Human Umbilical Cord Mesenchymal Stem Cells Alleviate Diabetic Nephropathy by Inhibiting Ferroptosis via the JNK/KEAP1/NRF2 Signaling Pathway
Antioxidants & Redox Signaling · 2025
DOI: 10.1089/ars.2024.0575 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2025. Verfasst von Yuexin Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Hospital of Jilin University, Changchun, P.R. China. Hauptthemen laut MEDLINE: Ferroptosis, NF-E2-Related Factor 2, Mesenchymal Stem Cells, Diabetic Nephropathies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
Aims
Diabetic nephropathy (DN) is a major cause of end-stage renal disease, with no therapeutic interventions available to control its progression. Ferroptosis, an iron-dependent regulated cell death characterized by lipid peroxidation, plays a pivotal role in the pathogenesis of DN. Human umbilical cord mesenchymal stem cells (hUCMSCs) are an effective treatment modality for DN; however, the underlying mechanism of action remains unclear. The aim of the present study was to investigate whether hUCMSCs alleviate DN via inhibiting ferroptosis and its molecular mechanisms in type 2 diabetic mice and high-glucose and palmitate-stimulated human renal tubular epithelial cell (HK-11) models.
Results
Our findings revealed that hUCMSCs improved the renal structure and function and tubular injuries. HUCMSC treatment can inhibit ferroptosis by decreasing iron content, reducing reactive oxygen species, malondialdehyde and 4-hydroxynonenal generation, decreasing the expression of positive ferroptosis mediator transferrin receptor 1 and long-chain acyl-CoA synthetase 4, and enhancing the expression of negative ferroptosis mediators ( i.e., ferritin heavy chain, glutathione peroxidase 4, and system Xc-cystine/glutamate reverse transporter). Mechanistically, hUCMSC treatment inhibited c-Jun N-terminal kinase (JNK) and Kelch-like ECH-associated protein 1 (KEAP1) activation while increasing the expression of nuclear factor erythroid 2-related factor 2 (NRF2). Furthermore, pretreatment of HK-11 cells with NRF2 siRNA, the JNK inhibitor SP600125, or the JNK agonist anisomycin demonstrated the regulation of the JNK/KEAP1/NRF2 signaling pathway by hUCMSCs. Innovation and Conclusion: HUCMSCs inhibit ferroptosis in DN via the JNK/KEAP1/NRF2 signaling pathway, providing a new perspective and scientific evidence for treating DN. Antioxid. Redox Signal. 42, 807–826.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The Second Hospital of Jilin University, Changchun, P.R. China.
- Department of Radiology, Changchun Stomatological Hospital, Changchun, P.R. China.
- Research and Development Department, Jilin Tuohua Biotechnology Co., Ltd., Siping, P.R. China.
ORCID-Profile: Ping Luo
Zitieren
APA
Zhu, Y., Dong, C., Xu, Z., Lou, Y., Tian, N., Guan, Y., Nie, P., Luo, M., & Luo, P. (2025). Human Umbilical Cord Mesenchymal Stem Cells Alleviate Diabetic Nephropathy by Inhibiting Ferroptosis via the JNK/KEAP1/NRF2 Signaling Pathway. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2024.0575
Vancouver
Zhu Y, Dong C, Xu Z, Lou Y, Tian N, Guan Y, et al. Human Umbilical Cord Mesenchymal Stem Cells Alleviate Diabetic Nephropathy by Inhibiting Ferroptosis via the JNK/KEAP1/NRF2 Signaling Pathway. Antioxidants & Redox Signaling. 2025. doi:10.1089/ars.2024.0575
BibTeX
@article{Zhu2025,
author = {Zhu, Yuexin and Dong, Changqing and Xu, Zhiheng and Lou, Yan and Tian, Na and Guan, Yucan and Nie, Ping and Luo, Manyu and Luo, Ping},
title = {Human Umbilical Cord Mesenchymal Stem Cells Alleviate Diabetic Nephropathy by Inhibiting Ferroptosis via the JNK/KEAP1/NRF2 Signaling Pathway},
journal = {Antioxidants & Redox Signaling},
year = {2025},
doi = {10.1089/ars.2024.0575}
}
EUVIMED